Display options
Cite
Cantin A, Lahaie A, Odobasic B, et al. Evaluation of a continuous quality improvement program in anticoagulant therapy: Feasibility, satisfaction and perception. Can Pharm J (Ott). 2016;149(6):352-361doi: 10.1177/1715163516671334.
Cantin, A., Lahaie, A., Odobasic, B., Tremblay, M. P., Wazzan, D., Caron, S., Leblanc, C., Martineau, J., & Lalonde, L. (2016). Evaluation of a continuous quality improvement program in anticoagulant therapy: Feasibility, satisfaction and perception. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC, 149(6), 352-361. https://doi.org/10.1177/1715163516671334
Cantin, Ariane, et al. "Evaluation of a continuous quality improvement program in anticoagulant therapy: Feasibility, satisfaction and perception." Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC vol. 149,6 (2016): 352-361. doi: https://doi.org/10.1177/1715163516671334
Cantin A, Lahaie A, Odobasic B, Tremblay MP, Wazzan D, Caron S, Leblanc C, Martineau J, Lalonde L. Evaluation of a continuous quality improvement program in anticoagulant therapy: Feasibility, satisfaction and perception. Can Pharm J (Ott). 2016 Nov;149(6):352-361. doi: 10.1177/1715163516671334. Epub 2016 Oct 06. PMID: 27829859; PMCID: PMC5089331.
Copy Download .nbib Format: NLM
Share it on

Can Pharm J (Ott). 2016 Nov;149(6):352-361. doi: 10.1177/1715163516671334. Epub 2016 Oct 06.

Evaluation of a continuous quality improvement program in anticoagulant therapy: Feasibility, satisfaction and perception.

Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC

Ariane Cantin, Alexandre Lahaie, Bojan Odobasic, Marie-Philip Tremblay, Dana Wazzan, Stéphanie Caron, Caroline Leblanc, Josée Martineau, Lyne Lalonde

Affiliations

  1. Faculty of Pharmacy (Cantin, Lahaie, Odobasic, Tremblay, Wazzan, Lalonde), Université de Montréal, Montreal, and the Department of Pharmacy (Caron, Leblanc, Martineau), Hôpital de la Cité de la Santé, Laval, Québec (at the time the original draft was written).

PMID: 27829859 PMCID: PMC5089331 DOI: 10.1177/1715163516671334

Abstract

BACKGROUND: The ACO Program (Programme ACO), a continuous quality improvement program (CQIP) in anticoagulation therapy, was offered in community pharmacies as a pilot project.

OBJECTIVE: To evaluate the participants' appreciation for the various activities of the program.

METHODS: Participants had access to training activities, including an audit with feedback, online training activities (OTA), clinical tools and support from facilitators. Cognitive behavioural learning determinants were evaluated before and 5 months after the beginning of the program. Participants' satisfaction and perception were documented via online questionnaires and a semistructured interview.

RESULTS: Of the 52 pharmacists in the ACO Program, 47 participated in this evaluation. Seventy-seven percent of the participants completed at least 1 OTA and 6% published on the forum. The feeling of personal effectiveness rose from 8.01 (7.67-8.35) to 8.62 (8.24-8.99). The audit and feedback, as well as the high-quality OTA and their lecturers, were the most appreciated elements.

DISCUSSION: There was a high OTA participation rate. The facilitators seemed to play a key role in the CQIP. The low level of participation in the forum reflects the known phenomenon of social loafing. Technical difficulties affecting the platform and data collection for the audit with feedback constituted limitations.

CONCLUSION: The CQIP in anticoagulation therapy is appreciated by community pharmacists and is associated with an improved feeling of personal effectiveness.

Conflict of interest statement

Declaration of Conflicting Interests:All authors completed and submitted the International Committee of Medical Journal Editors form for divulging potential conflicts of interest. No conflict of inter

References

  1. JAMA. 1999 Oct 20;282(15):1458-65 - PubMed
  2. Med Educ. 2006 Apr;40(4):314-21 - PubMed
  3. Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259 - PubMed
  4. Ann Fam Med. 2012 Jan-Feb;10(1):63-74 - PubMed
  5. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000409 - PubMed
  6. BMC Fam Pract. 2011 Aug 17;12:88 - PubMed
  7. J Am Pharm Assoc (2003). 2004 Jul-Aug;44(4):467-71 - PubMed
  8. Med J Aust. 2014 Aug 4;201(3 Suppl):S47-51 - PubMed
  9. Res Social Adm Pharm. 2014 Jan-Feb;10 (1):45-57 - PubMed
  10. Int J Pharm Pract. 2012 Apr;20(2):107-17 - PubMed
  11. Healthc Policy. 2013 Feb;8(3):58-67 - PubMed
  12. J Am Pharm Assoc (Wash). 1999 May-Jun;39(3):368-74 - PubMed
  13. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003030 - PubMed
  14. Am J Health Syst Pharm. 2013 Jul 1;70(13):1154-61 - PubMed
  15. J Med Internet Res. 2014 Feb 04;16(2):e33 - PubMed

Publication Types